AmirAli Talasaz sold $5.9M of GH
Co-Chief Executive Officer at Guardant Health, Inc.. 120,716 shares at an average of $49.18, traded May 1, 2025, filed May 5, 2025.
Score components
- +25RoleCEO
- +25Trade size$5.9M at market
- 0Share of holdings soldSold 5.2% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001576280-25-000141, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 1, 2025 | SOpen-market sale Common Stock10b5-1 | -18,069 | $47.67 | $861k | 2,291,387 | May 5, 2025 |
| May 1, 2025 | SOpen-market sale Common Stock10b5-1 | -38,477 | $48.71 | $1.9M | 2,252,910 | May 5, 2025 |
| May 1, 2025 | SOpen-market sale Common Stock10b5-1 | -44,691 | $49.53 | $2.2M | 2,208,219 | May 5, 2025 |
| May 1, 2025 | SOpen-market sale Common Stock10b5-1 | -3,445 | $50.91 | $175k | 2,204,774 | May 5, 2025 |
| May 1, 2025 | SOpen-market sale Common Stock10b5-1 | -1,748 | $51.56 | $90k | 2,203,026 | May 5, 2025 |
| May 1, 2025 | SOpen-market sale Common Stock10b5-1 | -354 | $52.57 | $19k | 2,202,672 | May 5, 2025 |
| May 2, 2025 | SOpen-market sale Common Stock10b5-1 | -13,932 | $50.47 | $703k | 2,188,740 | May 5, 2025 |
Related signals
Other insiders at Guardant Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | Guardant Health, Inc. | Alex M Azar II director | $145k 826 shares | -50% | |
| 55Moderate | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $1.4M 7,738 shares | -10% | |
| 65Notable | Guardant Health, Inc. | Steve E. Krognes director | $1.2M 6,674 shares | -46% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $20k 116 shares | -1% | |
| 50Moderate | Guardant Health, Inc. | Kumud Kalia Chief Information Officer | $632k 4,000 shares | -9% | |
| 52Moderate | GHsell Guardant Health, Inc. | Michael Brian Bell Chief Financial Officer | $8.3M 80,362 shares | -74% | |
| 0Weak | Guardant Health, Inc. | Myrtle S Potter director | $1,446 26 shares | -0% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $6,453 116 shares | -2% | |
| 60Notable | Guardant Health, Inc. | Medina Manuel Hidalgo director | $117k 2,165 shares | -72% | |
| 70Notable | Guardant Health, Inc. | Helmy Eltoukhy Co-Chief Executive Officer | $18M 300,000 shares | -12% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.